Olarte, Alicent Kaori M.

HRN: 24-86-96  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/04/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
06/04/2025
06/10/2025
ORAL
3ml
Q8
Intestinal Amoebiasis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: